Recombinant FVIIIFc Versus BAY 94-9027 For Treatment of Patients with Haemophilia A: Comparative Efficacy Using a Matching Adjusted Indirect Comparison
mediaposted on 2021-01-04, 18:15 authored by Zalmai Hakimi, Elena Santagostino, Maarten J. Postma, Jameel Nazir
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.